A decision, likely to come in June, would be a major victory for the FDA’s authority to regulate prescription drugs and for abortion-rights advocates who have sought to protect access to mifepristone.
Related Posts
Biden administration pleads with states after millions of kids lose Medicaid coverage
- admin
- December 19, 2023
- 0
Becerra also asked the states to remove barriers to Children’s Health Insurance Program enrollment for children no longer eligible for Medicaid, reduce call center times […]
Anthony Fauci defends his Covid response, distances himself from adviser accused of misconduct
- admin
- June 4, 2024
- 0
The government’s former top infectious disease official said he didn’t suppress the debate over the coronavirus’ origin.
![](https://static.politico.com/30/5f/f38ecba04d539671569358fb7589/election-2024-trump-24855.jpg)
Trump promises a ‘deal’ on abortion that will please everyone. It likely doesn’t exist.
- admin
- April 7, 2024
- 0
Should Trump appear vague or duck the issue, some of his supporters fear it will allow the Biden campaign to tie him to the more […]